MediPharm cancels $5.5 million sale of Ontario cannabis facility to Kensana

Canadian cannabinoid company MediPharm Labs is halting the previously announced sale of its Napanee, Ontario, facility to Kensana Health.

MediPharm cancels $5.5 million sale of Ontario cannabis facility to Kensana is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Never miss a story. Subscribe today.

Subscribe To Newsletter


By submitting this form, you are consenting to receive marketing emails from: AZ Cannabis News. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact